PRF1 and neoplasm: In the tumor site, Th1 cells can mediate antitumor activity via the secretion of the effector cytokine IFN-γ and the CTL-mediated release of the pore-forming perforins and cytotoxic granzymes (Kepp et al., 2018; Farhood et al., 2019).